{"result": "(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital city of Spain, where various medical publications and research are conducted.)\n##\n(\"entity\"<|>EDITORIAL ERGON<|>ORGANIZATION<|>Editorial Ergon is a publishing house based in Madrid, known for publishing medical literature.)\n##\n(\"entity\"<|>EDITORIAL DRUG FARMA<|>ORGANIZATION<|>Editorial Drug Farma is a publishing house in Madrid that specializes in medical and clinical nutrition literature.)\n##\n(\"entity\"<|>EDITORIAL MASSON<|>ORGANIZATION<|>Editorial Masson is a publishing house located in Barcelona, focusing on medical and clinical publications.)\n##\n(\"entity\"<|>J NEUROL NEUROSURG PSYCHIATRY<|>ORGANIZATION<|>J Neurol Neurosurg Psychiatry is a medical journal that publishes research in neurology and neurosurgery.)\n##\n(\"entity\"<|>J MOL NEUROSCI<|>ORGANIZATION<|>J Mol Neurosci is a medical journal that focuses on molecular neuroscience research.)\n##\n(\"entity\"<|>PEDIATR INTEGRAL<|>ORGANIZATION<|>Pediatr Integral is a medical journal that publishes articles related to pediatric medicine.)\n##\n(\"entity\"<|>NUTRICIÓN Y DIETÉTICA CLÍNICA<|>EVENT<|>Nutrición y Dietética Clínica is a medical publication that discusses clinical nutrition and dietary treatments.)\n##\n(\"relationship\"<|>EDITORIAL ERGON<|>MADRID<|>Editorial Ergon is based in Madrid, contributing to the medical literature published in the city.<|>7)\n##\n(\"relationship\"<|>EDITORIAL DRUG FARMA<|>MADRID<|>Editorial Drug Farma is located in Madrid, focusing on medical publications.<|>7)\n##\n(\"relationship\"<|>EDITORIAL MASSON<|>BARCELONA<|>Editorial Masson is based in Barcelona, specializing in medical literature.<|>7)\n##\n(\"relationship\"<|>J NEUROL NEUROSURG PSYCHIATRY<|>EDITORIAL ERGON<|>J Neurol Neurosurg Psychiatry publishes articles that may be published by Editorial Ergon.<|>6)\n##\n(\"relationship\"<|>J MOL NEUROSCI<|>EDITORIAL MASSON<|>J Mol Neurosci publishes research that may be published by Editorial Masson.<|>6)\n##\n(\"relationship\"<|>PEDIATR INTEGRAL<|>EDITORIAL DRUG FARMA<|>Pediatr Integral publishes articles that may be published by Editorial Drug Farma.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN Y DIETÉTICA CLÍNICA<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>Nutrición y Dietética Clínica discusses topics relevant to the research conducted at Hospital Universitari de Bellvitge.<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: metabólicas hereditarias. Ma-\n      kodystrophy despite treatment with Lorenzo’s oil.                     drid, editorial Ergon, 2006.\n      J Neurol Neurosurg Psychiatry 1999; 67: 290-9.                   30.  Peña-Quintana L. Trastorno de la oxidación de los\n21.   Konijnenberg A, Van Geel BM, Sturk A, Schaap                          ácidos grasos. Pediatr Integral 2002; 6: 703-10.\n      MCL, Von Dem Borne AEG, De Bruijne LG                    et al.  31.  Ruiz Pons M, Sánchez-Valverde F, Dalmau J, Gó-\n      Lorenzo’s oil and platelet activation in adrenomye-                   mez L. Errores innatos del metabolismo de las gra-\n      loneuropathy and assymptomatic x-linked adreno-                       sas En: Ruiz M, Sánchez Valverde F, Dalmau J, Gó-\n      leukodystrophy. Platelets 1988; 9: 41-8.                              mez L (eds) Tratamiento nutricional de los errores\n22.   Mosser HW, Mosser AB, Hollandsworth K, Brere-                         innatos del metabolismo. Madrid, Editorial Drug\n      ton NH, Raymond GV. «Lorenzo’s oil» therapy for                       Farma 2007.\n      X-kinked adrenoleukodystrophy: rationale and cu-                 32.  Virgili N, Forga M, García-Raimundo EM. Dieta\n      rrent assessment of efficacy. J Mol Neurosci 2007;                    controlada en triglicéridos de cadena larga y en\n      33: 105-13.                                                           triglicéridos de cadena media. En: Salas J, Bonada\n23.   Krivit W, Peters C, Shapiro EG. Bone marrow trans-                    A, Trallero R, Saló ME, Burgos R Eds. Nutrición y\n      plantation as effective treatment of central nervous                  Dietética Clínica. Madrid, Editorial Masson, Barce-\n      system disease in globoid cell leukodystrophy,meta-                   lona 2014.\n---\nTema 21.\nQuilotórax y ascitis quilosa. Dietas modificadas\nen triglicéridos de cadena larga y cadena media\nM.ª Nuria Virgili Casas\nRafael López Urdiales\nEva María García Raimundo\nMónica Montserrat Gil de Bernabé\nUnidad de Nutrición y Dietética. Servicio de Endocrinología y Nutrición.\nHospital Universitari de Bellvitge. Hospitalet de Llobregat. Barcelona\n\n\n\nDietoterapia, nutrición clínica y metabolismo. Tercera edición. Copyright 2017 de los autores, SEEN y Grupo Aula Médica.\nTodos los derechos reservados. Páginas 353-363.\n\n\n\n  1.   Introducción\n  2.   Manifestaciones clínicas\n  3.   Diagnóstico\n  4.   Repercusión nutricional e inmunológica de las lesiones del sistema linfático\n  5. Tratamiento\n  6.   Resumen y conclusiones\n  7.   Bibliografía\n\n\n\n1.  Introducción\n  El quilo es un líquido que contiene en suspensión los                                           Vena yugular\nproductos de la digestión y absorción de la grasa con-                         Conducto              interna\ntenida en los alimentos y especialmente los triglicéridos                       torácico\nde cadena larga (TCL). Es transportado por los conduc-                          derecho\ntos linfáticos a la circulación a través del conducto to-                                               T1                  Conducto\nrácico. Aproximadamente entre el 70-90% de la grasa                                                                         torácico\ningerida circula a través de este sistema.                                                                                 Vena\n  Los conductos linfáticos actúan como mecanismo                                Vena cava\nde drenaje facilitando el retorno de fluidos, lípidos y                            superior                                subclavia\nproteínas desde los tejidos al sistema vascular a través                                T5                                  Aorta\nde la cisterna quilosa y el conducto torácico. La cister-                    Vena ácigos                                     Conducto\nna quilosa está formada por tres troncos linfáticos:                                                                         torácico\ndos troncos lumbares de cada una de las extremidades\ninferiores y un tronco intestinal (fig. 1). De la cisterna\nquilosa deriva el conducto torácico que entra en el tó-\nrax a través del hiato aórtico ascendiendo por el me-\ndiastino posterior en el hemitórax derecho hasta la                               Vena cava\ncuarta o quinta vértebra torácica, en que pasa al hemi-                               inferior                              Esófago\ntórax izquierdo, anterior a la arteria subclavia y desem-                        Cisterna                        T12\nboca en el sistema venoso en la confluencia de la vena                            quilosa\nsubclavia y la vena yugular interna izquierdas. Var\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>ORGANIZATION<|>Hospital Universitari de Bellvitge is a hospital located in Hospitalet de Llobregat, Barcelona, specializing in endocrinology and nutrition.)\n##\n(\"entity\"<|>M.ª NURIA VIRGILI CASAS<|>PERSON<|>M.ª Nuria Virgili Casas is a medical professional involved in the study of dietary treatments and clinical nutrition.)\n##\n(\"entity\"<|>RAFAEL LÓPEZ URDIALES<|>PERSON<|>Rafael López Urdiales is a medical professional contributing to the research on nutrition and metabolism.)\n##\n(\"entity\"<|>EVA MARÍA GARCÍA RAIMUNDO<|>PERSON<|>Eva María García Raimundo is a medical professional focused on dietary therapy and clinical nutrition.)\n##\n(\"entity\"<|>MÓNICA MONTSERRAT GIL DE BERNABÉ<|>PERSON<|>Mónica Montserrat Gil de Bernabé is a medical professional working in the field of nutrition and dietetics.)\n##\n(\"entity\"<|>QUILOTÓRAX<|>EVENT<|>Quilotórax is a medical condition involving the accumulation of lymphatic fluid in the pleural cavity.)\n##\n(\"entity\"<|>ASCITIS QUILOSA<|>EVENT<|>Ascitis quilosa is a medical condition characterized by the accumulation of chyle in the abdominal cavity.)\n##\n(\"relationship\"<|>M.ª NURIA VIRGILI CASAS<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>M.ª Nuria Virgili Casas is associated with the Hospital Universitari de Bellvitge, where she works in the field of nutrition and dietetics.<|>8)\n##\n(\"relationship\"<|>RAFAEL LÓPEZ URDIALES<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>Rafael López Urdiales is associated with the Hospital Universitari de Bellvitge, contributing to research in nutrition and metabolism.<|>8)\n##\n(\"relationship\"<|>EVA MARÍA GARCÍA RAIMUNDO<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>Eva María García Raimundo is associated with the Hospital Universitari de Bellvitge, focusing on dietary therapy and clinical nutrition.<|>8)\n##\n(\"relationship\"<|>MÓNICA MONTSERRAT GIL DE BERNABÉ<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>Mónica Montserrat Gil de Bernabé is associated with the Hospital Universitari de Bellvitge, working in nutrition and dietetics.<|>8)\n##\n(\"relationship\"<|>QUILOTÓRAX<|>ASCITIS QUILOSA<|>Quilotórax and ascitis quilosa are both medical conditions related to the accumulation of lymphatic fluid in the body.<|>5)\n<|COMPLETE|>"}]}